Identification of cerebrospinal fluid pharmacodynamic biomarkers and molecular correlates of brain activity in a Phase 2 clinical trial of the Alzheimer&#39;s disease drug candidate CT1812.

Elayta (zervimesine) - Cognition Therap

http://www.ncbi.nlm.nih.gov/pubmed/40547328

Anthony O Caggiano; Charlotte E Teunissen; Duc Duong; Eunah Cho; Everard G Vijverberg; Hilary A North; Jill Caldwell; Kiran Pandey; Mary E Hamby; Michael Grundman; Nicholas T Seyfried; Valentina Di Caro; Willem de Haan

Jun 24, 2025